Truist analyst Jordan Levy lowered the firm’s price target on QuantumScape to $7 from $10 and keeps a Hold rating on the shares. Based on where QuantumScape is in its development cycle, the progress and timeline updates related to the company’s QSE-5 flagship battery cell product will likely continue to outweigh the quarterly financial results as it relates to share reaction, the analyst tells investors in a research note. The firm adds that its reduced price target reflects increased cost of capital assumptions in its model.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on QS:
- Options Volatility and Implied Earnings Moves Today, October 25, 2023
- Quantumscape call volume above normal and directionally bullish
- QuantumScape initiated with an Outperform at Evercore ISI
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue